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INTRODUCTION
Caffeine is a widely consumed psychoactive stimulant [1]. A nation-
al-level survey indicated a high prevalence of caffeine intake among 
the general population [1]. Caffeine is also often consumed by ath-
letes, as recent data showed that urinary caffeine concentration after 
competitions is detectable in the majority of athletes [2, 3]. The 
popularity of caffeine among athletes is likely due to its ergogenic 
effects on exercise performance [4]. Current evidence indicates that 
caffeine ingestion may enhance different components of exercise 
performance [4]. For example, caffeine ingestion was reported to be 
ergogenic for aerobic and muscle endurance, muscle strength, as 
well as sprint and speed performance [4].
Studies have also explored caffeine’s effects on performance in 
different vertical jump tasks [4–10]. Two meta-analyses pooled 
the data from individual studies and reported ergogenic effects of 
caffeine ingestion on vertical jump height [11, 12]. Despite the 
positive effects of caffeine on jump height, caffeine’s effects on 
other components of vertical jump performance remain largely 
unexplored. Even though jump height is certainly of importance, 
vertical jump performance is also described by variables such as 
peak force, power, velocity, time to peak force and power, impulse, 
rate of power development, and others [13]. Some of these variables 
may be of substantial practical importance. For example, 
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countermovement jump (CMJ) variables such as mean power, time 
to peak power, rate of force development, and velocity at peak 
power are suggested to be highly sensitive for neuromuscular fatigue 
monitoring [14]. Furthermore, some CMJ-derived variables, such 
as peak power and peak velocity, are significantly correlated with 
maximum speed and muscular strength [13, 15]. Additionally, 
research demonstrated that CMJ impulse and mean power are able 
to discriminate between senior and academy rugby league players 
and different levels of elite status among handball players [16, 17]. 
Despite their practical importance, the effects of caffeine on these 
outcomes are rarely reported and analyzed in the scientific literature. 
Indeed, jump height is an outcome that is almost exclusively re-
ported in previous research [4–10].
Given that several different variables evaluate overall jump per-
formance, practitioners utilizing vertical jump tests on a force plate 
are likely to be interested in a wide array of outcomes, not only 
vertical jump height. Therefore, this study aimed to conduct a com-
prehensive examination of caffeine’s effects on vertical jump per-
formance. It was hypothesized that caffeine ingestion would 
be acutely ergogenic for jump height and all other recorded 
outcomes.
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Estimation of habitual caffeine intake was performed using a pre-
viously validated questionnaire [23]. Victoria University Human 
Research Ethics Committee provided ethical approval for this study 
(HRE19–019), which was registered at the Australian New Zealand 
Clinical Trials Registry (ID: ACTRN12619000885190). Every 
participant signed informed consent.
Testing protocol
Before the CMJ test, the participants first performed a warm-up 
protocol that involved one minute of running followed by ten body-
weight squats. CMJ testing was performed on a force platform 
(400S Isotronic Fitness Technology, Skye, South Australia, Austra-
lia). The reliability of data obtained from this force platform has 
been reported elsewhere [24]. The participants first positioned 
themselves on the force platform in an upright standing position. 
A computer screen was set in front of the platform. On this screen, 
commands from the software associated with the force plate were 
displayed. This software first counted down “3, 2, 1” followed by 
“Set” and “Go” commands. Within five seconds of the “Go” com-
mand, the participants were required to perform the jump. The 
participants were required to perform a fast downward counter-
movement to a semi-squat position followed by an “explosive” 
extension of the legs. Before starting with the test, the participants 
were instructed to jump as quickly and “explosively” as possible. 
A total of four jumps were performed, namely, one warm-up jump 
and three main attempts. Between each jump, the participants 
were provided with one minute of rest. For the analysis, the best 
values from the three jumps were used. In this study, the following 
outcomes were examined: peak force; mean force; force at ec-
centric to concentric action transition; time to peak force; peak 
power; mean power; maximum rate of power development; time 
to peak power; peak velocity; impulse at 300 ms; force at peak 
power; power at peak force; velocity at peak power; velocity at 
peak force; and vertical jump height. The description of these CMJ 
variables is provided in detail elsewhere [14, 25].
Side effects
The incidence of side effects associated with caffeine and placebo 
supplementation was examined twice: (a) immediately after the test-
ing sessions; and, (b) in the following mornings, upon waking. We 
used an 8-item survey that included a yes/no response scale for the 
evaluation of side effects.
Effectiveness of blinding
The effectiveness of blinding was examined, as proposed by Saunders 
and colleagues [26]. Specifically, immediately before and after both 
main testing sessions, the participants were asked to respond to the 
following question: “Which supplement do you think you have in-
gested?”. This question had three possible answers: (a) “caffeine”, 
(b) “placebo” and (c) “I do not know”.
MATERIALS AND METHODS 
Design
This study utilized a double-blind, randomized, counterbalanced, 
and crossover design. In total, the participants went through the 
testing protocol four times: two familiarization sessions and two main 
sessions. To minimize the effect of diurnal biological variations, each 
participant was tested at the same time of day [18]. All testing ses-
sions were performed in the morning hours (between 07:00 and 
12:00 h). A minimum of four and a maximum of seven days sepa-
rated every testing session. After the two practice sessions, the two 
main trials were performed. These trials included the ingestion of 
caffeine or placebo. In these sessions, the participants came to the 
testing laboratory in a fasted state (overnight fast). Caffeine and 
placebo were administered in a capsule form. Caffeine was provided 
in a dose of 3 mg per kg of body mass, while the placebo contained 
3 mg/kg of dextrose. A caffeine dose of 3 mg/kg was used given that 
it has been previously reported to be ergogenic [7]. In both cases 
(i.e., caffeine and placebo trials), the capsules were ingested 60 min-
utes pre-exercise; this timing of ingestion is suggested to correspond 
to peak plasma caffeine concentrations [19]. This timing of ingestion 
was also used in most other studies that explored the effects of caf-
feine on exercise performance [5–8, 20]. In order to ensure a double-
blind study design, caffeine and placebo capsules were of the same 
appearance and were provided to the participants in sealed envelopes. 
When the exercise session started, the participants first performed 
an upper-body resistance exercise that lasted around 30 minutes 
(results reported elsewhere [21, 22]). Therefore, CMJ performance 
was evaluated 90 minutes after ingestion of caffeine or placebo. On 
the days before the main sessions, the participants were advised not 
to perform any strenuous activity and to keep a food diary. On the 
days before the main sessions, the participants were also required 
to restrict caffeine ingestion after 6 pm.
Participants
Resistance-trained men were included as study participants. All 
included participants had a minimum of six months of resistance 
training experience with a minimum training frequency of two days 
per week (on most weeks). Participants were excluded from this 
study if they reported: (a) use of anabolic steroids (prior or current); 
and/or (b) the existence of any health limitations. Power analysis 
was calculated using G*Power (version 3.1.9.2, University Düs-
seldorf, Germany). Assuming ANOVA, repeated measures, within 
factors as the statistical test, 0.15 as the expected effect size (f) for 
vertical jump height (determined using meta-analytical data [11]), 
0.05 as α, the statistical power of 0.80, 1 group, 2 measurements, 
and r of 0.90 the power analysis indicated that the required sam-
ple size was n = 20. A total of 22 men (mean ± standard devia-
tion of age: 28 ± 5 years; height: 183 ± 5 cm; weight: 79 ± 10 kg; 
habitual caffeine intake: 127 ± 102 mg/day) enrolled in the study, 
and all participants completed the testing sessions without any 
dropouts or any other adverse events.
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Statistical analysis
Shapiro–Wilk test was used for evaluating the normality of distribu-
tion. After confirming normality of distribution, all CMJ performance 
outcomes were analyzed using one-way repeated-measures analysis 
of variance (ANOVA). Hedges’ g for repeated measures was used to 
calculate relative effect sizes (ES) and their respective 95% confidence 
intervals. ESs were interpreted using the following scale: < 0.20 as 
trivial, 0.20–0.49 as small, 0.50–0.79 as moderate, and ≥ 0.80 as 
large. McNemar’s test was used to explore possible differences in 
the incidence of side effects between caffeine and placebo conditions. 
The data on participants blinding were examined using Bang’s Blind-
ing Index. These data are reported as a percentage of participants 
that identified the conditions beyond random chance. All analyses 
were performed using the Statistica software (version 13.0; StatSoft; 




As compared to placebo, there was a significant ergogenic effect of 
caffeine for peak force (p = 0.046; ES: 0.11), force at eccentric to 
concentric action transition (p = 0.041; ES: 0.14), time to peak 
force (p = 0.048; ES: 0.28), peak power (p = 0.020; ES: 0.16), 
maximum rate of power development (p = 0.018; ES: 0.13), peak 
velocity (p = 0.005; ES: 0.32), power at peak force (p = 0.038; 
ES: 0.38), velocity at peak power (p = 0.007; ES: 0.38), velocity 
at peak force (p = 0.002; ES: 0.24), and vertical jump height 
(p = 0.010; ES: 0.14). There were no significant differences 
(p > 0.05 for all) between caffeine and placebo for mean force, mean 
power, time to peak power, impulse at 300 ms, and force at peak 
power. All analyzed data are summarized in Table 1.
Side effects
When assessed immediately after the testing sessions, there were 
significant differences only in “increased vigor/activeness” (p = 0.009) 
and “perception of improved performance” (p = 0.002). In both 
cases, the incidence of these side effects was higher in the caffeine 
condition. No significant differences between caffeine and placebo 
were found when side effects were assessed in the mornings after 
the testing sessions (Table 2).
Effectiveness of blinding
When assessed before exercise, 55% and 59% of the participants 
correctly identified the caffeine and placebo conditions beyond ran-
dom chance, respectively. When assessed immediately after exercise, 
68% and 72% of the participants correctly identified the placebo 
and caffeine conditions beyond random chance, respectively.
DISCUSSION 
The main finding of this study is that caffeine ingestion was acutely 
ergogenic for vertical jump height and other outcomes derived from 
the force plate during the CMJ test. In addition to jump height, 






ES and its 95% CI p-value
Peak force (N) 1756 ± 267 1787 ± 286 0.11 (0.00, 0.22) 0.046
Mean force (N) 793 ± 102 789 ± 97 –0.04 (–0.10, 0.02) 0.316
Force at eccentric to concentric action transition (N) 1625 ± 310 1669 ± 313 0.14 (0.00, 0.28) 0.041
Time to peak force (s) 0.75 ± 0.25 0.68 ± 0.23 0.28 (0.01, 0.57) 0.048
Peak power (W) 3791 ± 667 3902 ± 658 0.16 (0.03, 0.30) 0.020
Mean power (W) 705 ± 139 700 ± 156 –0.03 (0.33, 0.26) 0.821
Maximum rate of power development (W/s) 13633 ± 4433 14194 ± 4171 0.13 (0.01, 0.24) 0.018
Time to peak power (s) 0.28 ± 0.06 0.27 ± 0.05 0.07 (–0.05, 0.19) 0.274
Peak velocity (m/s) 2.67 ± 0.21 2.73 ± 0.19 0.32 (0.10, 0.56) 0.005
Impulse at 300 ms (Ns) 239 ± 30 238 ± 28 –0.03 (–0.10, 0.03) 0.187
Force at peak power (N) 1566 ± 254 1567 ± 259 0.00 (–0.05, 0.06) 0.924
Power at peak force (W) 3539 ± 524 3751 ± 508 0.38 (0.02, 0.78) 0.038
Velocity at peak power (m/s) 2.45 ± 0.21 2.53 ± 0.21 0.38 (0.11, 0.68) 0.007
Velocity at peak force (m/s) 2.15 ± 0.27 2.21 ± 0.24 0.24 (0.09, 0.43) 0.002
Vertical jump height (cm) 35.1 ± 5.7 35. 9 ± 5.7 0.14 (0.03, 0.25) 0.010
ES: effect size: CI: confidence interval; SD: standard deviation.
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greater increases in velocity outcomes in the CMJ test, even though 
future dose-response studies are needed to explore this topic further.
A substantial focus has been recently placed on the relationship 
between vertical jump height and power [30]. Even though jump 
height is generally not considered a good indicator of lower limb 
power output, increased jump height following caffeine ingestion is 
commonly interpreted as an increase in ‘power’ [5, 6]. Several stud-
ies that evaluated jump height and power reported ergogenic effects 
of caffeine on both outcomes [31, 32]. However, other studies re-
ported that improvements in jump height occur independently of 
changes in power [33, 34]. In this study, caffeine affected some, but 
not all power variables. Specifically, following caffeine ingestion, we 
observed improvements in peak power, maximum rate of power de-
velopment, and power at peak force. However, there was no significant 
difference between caffeine and placebo in mean power, suggesting 
that the relationship between caffeine-induced changes in vertical 
jump height and power is dependent on the analyzed power outcome.
While caffeine ingestion enhanced several aspects of CMJ perfor-
mance, there was no significant difference between caffeine and 
placebo for mean force, mean power, time to peak power, impulse 
at 300 ms, and force at peak power. The lack of an ergogenic effect 
of caffeine on these outcomes might be related to their test-retest 
reliability. One study [35] reported that the coefficient of variation 
(CV) for test-retest reliability of mean power is between 7.8% and 
12.3%. For time to peak power, this study reported CVs from 7.0% 
to 14.4%. It might be that the lack of an ergogenic effect of caffeine 
on these outcomes is explained by their lower test-retest reliability, 
which might have resulted in a type II error. This hypothesis seems 
plausible given that CVs for outcomes such as peak power and peak 
velocity are lower (1.3% to 3.3%), and for these outcomes, there 
was an ergogenic effect of caffeine [35].
caffeine increased: (a) peak force and force at eccentric to concentric 
action transition (while decreasing the time needed to reach peak 
force); (b) peak power, power at peak force, and maximum rate of 
power development; and, (c) peak velocity, velocity at peak power, 
and velocity at peak force. Despite the improvements in these out-
comes, no significant differences between caffeine and placebo were 
observed for mean force, mean power, time to peak power, impulse 
at 300 ms, and force at peak power.
Out of the analyzed outcomes, velocity variables seem to be par-
ticularly affected by caffeine ingestion. Indeed, all three velocity-
associated outcomes (i.e., peak velocity, velocity at peak power, and 
velocity at peak force) improved following caffeine ingestion. ESs for 
these outcomes ranged from 0.24 to 0.38. In line with this finding, 
research that examined the effects of caffeine on other velocity-based 
tasks (e.g., repetition velocity in resistance exercise) also reported 
substantial ergogenic effects of acute caffeine ingestion [27]. Caffeine 
ingestion was reported to increase muscle fiber conduction velocity 
and motor unit recruitment, which might explain this finding from 
a physiological perspective [28]. To our knowledge, only two studies 
examined the effects of caffeine ingestion on CMJ velocity vari-
ables [25, 29]. In one of these studies, Zbinden-Foncea et al. [25] 
also reported that caffeine ingestion (dose of 5 mg/kg) enhanced 
peak velocity and velocity at peak power. However, compared to the 
present study, Zbinden-Foncea et al. [25] reported larger performance-
enhancing effects of caffeine, as ES amounted to 0.79 and 0.90 for 
velocity at peak power and peak velocity, respectively. In another 
study [29], acute ingestion of caffeine in the dose of 3 mg/kg enhanced 
velocity at peak power by an ES of 0.28, which is much more 
similar to the ES of caffeine on velocity variables observed herein. 
Due to the difference in doses of caffeine used between the studies, 
these results might suggest that larger doses of caffeine produce 
TABLE 2. Self-perceived side effects reported immediately after testing session and in the morning after the testing session.
Variable





Morning after  
testing session
Morning after  
testing session
Muscle soreness 27% 14% 14% 14%
Increased urine production 14% 5% 9% 0%
Tachycardia and heart palpitations 5% 5% 0% 0%
Increased anxiety 0% 14% 0% 0%
Headache 9% 9% 14% 5%
Abdominal/gut discomfort 0% 0% 0% 0%
Insomnia n/a n/a 0% 9%
Increased vigor/activeness 14% 64%* 0% 14%
Perception of improved performance 14% 77%* n/a n/a
* significant differences between conditions calculated using McNemar’s test.
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From a practical perspective, there are two main areas where the 
results of this study are highly relevant. Caffeine ingestion elicited 
significant improvements in power, which is considered to be critical 
to the performance of many athletic tasks [36]. Therefore, the first 
practical application of the findings is that individuals interested in 
acute increases in power may consider supplementing with caffeine. 
Performance in CMJ is also reported to be correlated with speed and 
lower-body strength [13]. Therefore, increases in CMJ performance 
following caffeine ingestion may also be associated with improve-
ments in other components of exercise performance. The second 
main practical application of the findings is related to the standard-
ization of caffeine ingestion before testing. Evaluation of CMJ perfor-
mance on a force platform is more likely to be used for testing than 
for training purposes. Therefore, our results highlight the need for 
standardizing caffeine ingestion before CMJ testing, especially when 
aiming to conduct between-group comparisons.
The main strength of this study is the inclusion of a relatively large 
sample size. In the two meta-analyses that examined the effects of 
caffeine on vertical jump height performance, the median sample 
size per included study was 13 and 14 participants, respective-
ly [11, 12]. The total sample size in the present study is almost twice 
as large as these median values, which allowed the detection of small 
but potentially meaningful differences between conditions. The main 
limitation of this study pertains to the effectiveness of blinding. Spe-
cifically, 55% to 72% of participants correctly identified the caffeine 
or placebo conditions beyond random chance, respectively. This is 
important to mention, given that correct supplement identification 
may impact performance and therefore present a source of bias in 
sports nutrition research [26]. Additionally, the ergogenic effects 
presented herein are specific to a caffeine dose of 3 mg/kg and should 
not be generalized to the effects observed with lower or higher dos-
es of caffeine.
CONCLUSIONS 
This study found that caffeine ingestion was acutely ergogenic for 
peak force, force at eccentric to concentric action transition, time to 
peak force, peak power, maximum rate of power development, peak 
velocity, power at peak force, velocity at peak power, velocity at peak 
force, and vertical jump height in the CMJ test. From a practical 
perspective, the findings suggest that: (a) individuals interested in 
acute increases in CMJ performance may consider supplementing 
with caffeine; and, (b) caffeine intake should be standardized before 
CMJ testing.
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